Tatva Chintan Pharma IPO subscribed 4.51 times on first day of subscription https://ift.tt/eA8V8J

The portion meant for qualified institutional buyers (QIBs) was subscribed 50 per cent, while the non-institutional investors' category received 1.14 times subscription and those for retail individual investors (RIIs) 8.24 times, according to an update on NSE.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3Bd8TNG